发明名称 Methods for detecting human metapneumovirus
摘要 The present invention discloses specific human metapneumovirus monoclonal antibodies. The antibody is at least two-fold less reactive with non-human metapneumoviruses including, but not limited to, respiratory viruses or avian metapneumoviruses. Further, the antibody is at least two-fold more reactive with a human metapneumovirus (i.e., for example, Type A or Type B) than with non-human metapneumoviruses including, but not limited to, respiratory viruses or avian metapneumoviruses. Consequently, these novel antibodies are useful as a clinical diagnostic agent, especially when using fresh nasopharengeal aspirates. The invention also contemplates numerous diagnostic platforms that together with the novel antibodies can support economical, fast, and highly selective detection and identification of clinical inoculum samples.
申请公布号 US9535066(B2) 申请公布日期 2017.01.03
申请号 US201514841057 申请日期 2015.08.31
申请人 Diagnostic Hybrids, Inc. 发明人 Gerna Giuseppe;Sarasini Antonella;Revello Maria Grazia
分类号 G01N33/569;C07K16/10 主分类号 G01N33/569
代理机构 Medlen & Carroll, LLP 代理人 Medlen & Carroll, LLP
主权项 1. A method for detection of infection by a metapneumovirus, comprising: contacting a biological sample taken from an individual suspected of a metapneumovirus infection with a composition comprising one or more human metapneumovirus (hMPV)-specific monoclonal antibodies selected from the group consisting of an hMPV monoclonal antibody produced by C2C10, an hMPV monoclonal antibody produced by F4A1, and an hMPV monoclonal antibody produced by CB7F3.
地址 Athens OH US